These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37942138)

  • 21. Social determinants and lifestyle factors for brain health: implications for risk reduction of cognitive decline and dementia.
    Röhr S; Pabst A; Baber R; Engel C; Glaesmer H; Hinz A; Schroeter ML; Witte AV; Zeynalova S; Villringer A; Löffler M; Riedel-Heller SG
    Sci Rep; 2022 Jul; 12(1):12965. PubMed ID: 35902604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifestyle for Brain Health (LIBRA): a new model for dementia prevention.
    Schiepers OJG; Köhler S; Deckers K; Irving K; O'Donnell CA; van den Akker M; Verhey FRJ; Vos SJB; de Vugt ME; van Boxtel MPJ
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):167-175. PubMed ID: 28247500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele.
    Shahid M; Kim J; Leaver K; Hendershott T; Zhu D; Cholerton B; Henderson VW; Tian L; Poston KL
    Neurobiol Dis; 2019 Jul; 127():278-286. PubMed ID: 30826425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease.
    Ma LZ; Zhang C; Wang H; Ma YH; Shen XN; Wang J; Tan L; Dong Q; Yu JT
    J Parkinsons Dis; 2021; 11(3):1117-1127. PubMed ID: 33935105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.
    Leta V; Urso D; Batzu L; Weintraub D; Titova N; Aarsland D; Martinez-Martin P; Borghammer P; van Wamelen DJ; Yousaf T; Rizos A; Rodriguez-Blazquez C; Chung-Faye G; Chaudhuri KR
    J Parkinsons Dis; 2021; 11(3):1209-1219. PubMed ID: 33843697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
    Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting early cognitive decline in newly-diagnosed Parkinson's patients: A practical model.
    Hogue O; Fernandez HH; Floden DP
    Parkinsonism Relat Disord; 2018 Nov; 56():70-75. PubMed ID: 29936131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention.
    Cody KA; Koscik RL; Erickson CM; Berman SE; Jonaitis EM; Williams VJ; Mueller KD; Christian BT; Chin NA; Clark LR; Betthauser TJ; Johnson SC
    Alzheimers Dement (Amst); 2022; 14(1):e12351. PubMed ID: 36110432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
    Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ;
    J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.
    Chahine LM; Xie SX; Simuni T; Tran B; Postuma R; Amara A; Oertel WH; Iranzo A; Scordia C; Fullard M; Linder C; Purri R; Darin A; Rennert L; Videnovic A; Del Riva P; Weintraub D
    Parkinsonism Relat Disord; 2016 Jun; 27():102-6. PubMed ID: 27010070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease.
    Bejr-Kasem H; Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Eur J Neurol; 2021 Feb; 28(2):438-447. PubMed ID: 33032389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
    Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
    J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Socioeconomic position, modifiable dementia risk and cognitive decline: results of 12-year Maastricht Aging Study.
    Heger I; van Boxtel M; Deckers K; Bosma H; Verhey F; Köhler S
    Int Psychogeriatr; 2023 Oct; ():1-13. PubMed ID: 37905417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
    Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
    Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of concussion history as part of the LIfestyle for BRAin Health (LIBRA) modifiable factors risk score and associations with cognition in older former National Football League players.
    Brett BL; Aggarwal NT; Chandran A; Kerr ZY; Walton SR; DeFreese JD; Guskiewicz KM; Echemendia RJ; Meehan WP; McCrea MA; Mannix R
    Alzheimers Dement; 2023 Jul; 19(7):3087-3097. PubMed ID: 36708229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.